Research dossier
Ipamorelin — GHSR receptor selectivity dossier
A pentapeptide noted in the literature for its receptor selectivity.
Translated from the French original, which remains the reference version: lire en français →
Molecular identity
| Parameter | Value |
|---|---|
| CAS number | 170851-70-4 |
| Molar mass | 711.86 g/mol |
| Molecular formula | C₃₈H₄₉N₉O₅ |
| Sequence / nature | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Purity | ≥99% |
| Appearance | White lyophilised powder |
The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.
Research context
Receptor selectivity is what gives this pentapeptide its value as a pharmacological tool: a compound active at a single target supports conclusions that a promiscuous compound does not. It is on that basis that it appears frequently as a reference in selectivity panels.
Mechanism studied
Ipamorelin is a pentapeptide agonist at GHSR-1a, the ghrelin receptor, also called the growth hormone secretagogue receptor. It acts on a pathway distinct from that of GHRH: where the GHRH analogues activate the Gs-coupled GHRHR, ipamorelin activates a Gq-coupled receptor, with calcium mobilisation rather than cAMP accumulation as the measurable signal.
This difference in coupling explains why the two families are frequently studied together in the literature: they are two independent entry points to the same somatotropic axis, and their combination is an object of study in itself.
The feature most often emphasised in the publications is selectivity. Unlike earlier secretagogues of the same family, ipamorelin shows limited activity at corticotropic and prolactin receptors in binding assays. That selectivity, established by receptor panels, makes it a cleaner pharmacological tool for isolating the contribution of GHSR.
In-vitro literature
The published data include binding assays on receptor panels and functional calcium measurements on recombinant GHSR-1a. Protocols directly comparing it with GHRP-6 are frequent.
Bibliographic entry points
- PubMed — peer-reviewed literature
- PubChem — chemical profile and assay data
- NCBI — methodology and receptor references
These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.
Distinguishing this compound from its analogues
Acts at GHSR, not at GHRHR. That receptor distinction is essential when comparing with the GHRH analogues.
The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.
Methodological limits
The selectivity reported is established on receptor panels in recombinant systems; it does not predict behaviour in an integrated system, where the feedback loops absent in culture would operate. Calcium measurements are also sensitive to the level of receptor expression, which varies between cell lines.
These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.
Analytical parameters
A pentapeptide containing non-natural residues. Identity confirmation by mass spectrometry is indispensable, since close analogues have neighbouring masses.
| Parameter | Value |
|---|---|
| Storage | Store at −20 °C, protected from light |
| Solubility | Soluble in bacteriostatic water (BAC) |
| Stability | Stable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C |
| Control methods | RP-HPLC · MS · NMR |
Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.
Resulting concentrations
The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.
| Format | 1 ml | 2 ml | 3 ml |
|---|---|---|---|
| 10mg | 10.00 mg/ml | 5.00 mg/ml | 3.33 mg/ml |
These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.
Protocol design
Three points govern the validity of an assay using this material, whatever the question being asked.
The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.
The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.
The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.
Lot verification
The following formats are covered by a Janoshik Analytical report, readable from the product page:
- 10mg — lot report available
| Format | Lot report | Availability |
|---|---|---|
| 10mg | Covered | In stock |
The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.
Frequently asked questions
How does this product arrive?
As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.
Which solvent should be used for reconstitution?
Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.
How long does the material remain stable?
The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.
Does the analysis report correspond exactly to my vial?
The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.
Can this product be used on humans or animals?
No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.
See also: CJC-1295, Ipamorelin, GHRP-6: GHRH and GHRP compared
Dossiers in the same category
- CJC-1295 (zonder DAC) — CAS 863288-34-0
- GHRP-6 — CAS 87616-84-0
- IGF-1 LR3 — CAS 946870-92-4